Nanomedicine applied to translational oncology: A future perspective on cancer treatment

The relevant challenges to nanomedicine translation are presented and lie in the real difficulty to reach an advanced multidisciplinary forum for discussion, where not only experts from several field from academia, but also clinicians and professionals from the pharmaceutical/healthcare industries and regulatory bodies can take their part in sharing ideas, issues and unmet needs. The principal challenges that all stakeholders are facing are complex, and will be described in this review with a particular emphasis on scientific and regulatory issues.147